Home / Inspections / 1040884

FDA Inspection 1040884 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3005680856

The FDA completed an inspection of New York Blood Center Enterprises on February 7, 2018 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Port Jefferson Station, NY (United States)

Facility

Other inspections at this facility

  • 1302348 (VAI Wed Feb 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1132998 (NAI Thu Nov 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 952436 (NAI Wed Dec 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892079 (NAI Wed Aug 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 797574 (NAI Wed Sep 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources